ArticleMolecular cancer therapeutics2025

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

Kaushik Varadarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.